EP4660195A1 — Crystalline forms of avatrombopag maleate and preparation thereof
Assigned to Noucor Health SA · Expires 2025-12-10 · 0y expired
What this patent protects
The present invention relates to crystalline forms of Avatrombopag maleate, to a preparation method thereof, to pharmaceutical compositions comprising said solid forms and to the use thereof in medicine, particularly for increasing the level of platelets in a patient. The inventi…
USPTO Abstract
The present invention relates to crystalline forms of Avatrombopag maleate, to a preparation method thereof, to pharmaceutical compositions comprising said solid forms and to the use thereof in medicine, particularly for increasing the level of platelets in a patient. The invention also relates to the use of said solid form in the prevention or treatment of thrombocytopenia or chronic liver disease.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.